The American Diabetes Association Names Don Feltham as the Inaugural Regional Advocacy Council Advocate of the Year

Why It Matters

Celebrating Feltham spotlights the growing influence of grassroots advocates on diabetes legislation, reinforcing the ADA’s strategy to leverage community leaders for systemic change.

Key Takeaways

• ADA launches inaugural Regional Advocacy Advocate of the Year award
• Don Feltham recognized for grassroots diabetes policy advocacy
• Award presented during 2026 Call to Congress gathering
• Feltham’s service includes Cosmopolitan Club leadership and community awards
• Highlights ADA’s emphasis on volunteer-driven policy impact

Pulse Analysis

The American Diabetes Association’s creation of the Regional Advocacy Council Advocate of the Year award reflects a strategic shift toward formalizing recognition for community‑level champions. With more than 155 million Americans affected by diabetes or prediabetes, the ADA is leveraging high‑visibility honors to amplify voices that can translate personal experience into legislative action. By spotlighting an individual like Don Feltham, the organization signals that sustained volunteer effort is a critical pillar of its advocacy engine, encouraging other grassroots leaders to step forward.

Feltham’s journey illustrates how localized advocacy can ripple into national policy discussions. His involvement with the Heartland Santa Fe Trail Cosmopolitan Club—an organization that brands itself as “The Club that Fights Diabetes”—provided a platform to educate peers, mobilize volunteers, and lobby for expanded treatment access. At the 2026 Call to Congress, his testimony helped frame diabetes care as a bipartisan priority, showcasing the tangible outcomes when personal narratives intersect with data‑driven policy proposals. Such examples reinforce the ADA’s message that individual commitment, when organized through reputable community groups, can shape health legislation.

Looking ahead, the award sets a precedent for scaling volunteer influence across the United States. By institutionalizing accolades for advocacy excellence, the ADA creates a replicable model that other health nonprofits can adopt, fostering a network of informed, motivated advocates ready to engage lawmakers. This approach not only strengthens the ADA’s lobbying clout but also cultivates a pipeline of future leaders who can sustain momentum on issues like insulin affordability, research funding, and preventive education. Stakeholders—from corporate partners to policy makers—should monitor how this recognition program drives measurable policy shifts and consider similar strategies within their own advocacy frameworks.